Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01166
Species: Mus musculus
Position : chr8:121503787-121504483
Year: 2019
Title: Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Genome Build: mm39
Enhancer Type: Enhancer
Condition: Normal
PMID:  31406378
Tissue: bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: common dendritic cell progenitors and pre-cDC1
Cell Type: dendritic cell progenitor
Experiment Type: Chromatin accessibility assay; Functional perturbation assay; In vivo enhancer deletion assay
High Throughput Method: ATAC-seq; H3K27ac ChIP-seq; H3K4me1 ChIP-seq; chromatin profiling
Low Throughput Method: CRISPR/Cas9 enhancer deletion; E-box deletion analysis; RT-qPCR; flow cytometry; Flt3L bone-marrow differentiation assay; CRISPR-Cas9
About Target Gene
Target gene : Irf8
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (mm39) 6 found
Enhancer ID Position Tissue Cell Disease
E_01346 chr8:121503787-121504483 bone marrow dendritic cell lineage NA
E_01347 chr8:121503787-121504483 bone marrow dendritic cell lineage NA
E_03073 chr8:121503787-121504483 bone marrow plasmacytoid dendritic cell NA
E_03105 chr8:121503787-121504483 bone marrow dendritic cell progenitor NA
E_03106 chr8:121503787-121504483 bone marrow conventional dendritic cell precursor NA
E_03107 chr8:121503787-121504483 bone marrow conventional dendritic cell precursor NA
Expression of Target Genes for the Enhancer